/cloudfront-us-east-2.images.arcpublishing.com/reuters/LMZH3JPL4RLNHBGR7QRYIMJU4Y.jpg)
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/V2SCMTGPGZAVZJ3UGJBMBDTYZU.JPG)
Dec 1 (Reuters) – The European Medicines Agency’s (EMA) safety committee on Friday recommended changes to product information for all medicines that contain the ingredient pseudoephedrine...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/K6P5N7CEHBMHDGXYLMM6KFZ7WQ.jpg)
[1/2]People wait for their rides outside a children’s hospital in Beijing, China November 24, 2023. REUTERS/Florence Lo /File photo Acquire Licensing Rights SHANGHAI, Dec 1 (Reuters)...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HIWQMMD2UJKUBEH4CSY2A7U4P4.jpg)
Vials labelled “VACCINE Coronavirus COVID-19” and a syringe are seen in front of a displayed Novavax logo in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/6VJ775IZKRIFDKTKT4CU5RWBXE.jpg)
Valneva logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration/File photo Acquire Licensing Rights Nov 27 (Reuters) – French drugmaker Valneva (VLS.PA)...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7XXQIDEIWRKN3NZA62CUCEHSMM.jpg)
PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more...
Recent Comments